Acute myeloblastic leukemia (AML) with inv (16)(p13;q22) and the rare I type CBFβ-MYH11 transcript: report of two new cases
- 1 January 2002
- journal article
- Published by Springer Nature in Leukemia
- Vol. 16 (1) , 150-151
- https://doi.org/10.1038/sj.leu.2402332
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual diseaseLeukemia, 1999
- Inversion of chromosome 16 and uncommon rearrangements of the CBFB and MYH11 genes in therapy-related acute myeloid leukemia: rare events related to DNA-topoisomerase II inhibitors?Journal of Clinical Oncology, 1998
- Detection of CBFβ/MYH11 fusion transcripts in acute myeloid leukemia: heterogeneity of cytological and molecular characteristicsLeukemia, 1997
- RT-PCR diagnosis of patients with acute nonlymphocytic leukemia and inv(16)(p13q22) and identification of new alternative splicing in CBFB- MYH11 transcriptsBlood, 1995
- Heterogeneity in CBF beta/MYH11 fusion messages encoded by the inv(16)(p13q22) and the t(16;16)(p13;q22) in acute myelogenous leukemiaBlood, 1995
- Good Predictive Value of Combined Cytogenetic and Molecular Follow Up in Chronic Myelogenous Leukemia After Non T-cell Depleted Allogeneic Bone Marrow Transplantation: A Report on 38 Consecutive CasesLeukemia & Lymphoma, 1995
- Fusion Between Transcription Factor CBFβ/PEBP2β and a Myosin Heavy Chain in Acute Myeloid LeukemiaScience, 1993
- Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative GroupBritish Journal of Haematology, 1976